Intensity Therapeutics, Inc.
INTS
$0.282
-$0.009-3.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.02M | 5.37M | 6.09M | 6.40M | 6.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.87M | 15.24M | 16.59M | 16.73M | 15.66M |
| Operating Income | -12.87M | -15.24M | -16.59M | -16.73M | -15.66M |
| Income Before Tax | -12.58M | -15.01M | -16.27M | -16.26M | -15.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.58 | -15.01 | -16.27 | -16.26 | -15.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.58M | -15.01M | -16.27M | -16.26M | -15.08M |
| EBIT | -12.87M | -15.24M | -16.59M | -16.73M | -15.66M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.83 | -1.06 | -1.17 | -1.18 | -1.10 |
| Normalized Basic EPS | -0.52 | -0.66 | -0.73 | -0.74 | -0.69 |
| EPS Diluted | -1.05 | -1.28 | -1.39 | -1.18 | -1.10 |
| Normalized Diluted EPS | -0.52 | -0.66 | -0.73 | -0.74 | -0.69 |
| Average Basic Shares Outstanding | 62.25M | 57.09M | 55.63M | 54.99M | 54.85M |
| Average Diluted Shares Outstanding | 62.25M | 57.09M | 55.63M | 54.99M | 54.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |